Search

Author/Creator Rothenberg, Michael E.

1. A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Issue 1 (10th January 2022)

Authors:
Katz, Jonathan S.; Rothstein, Jeffrey D.; Cudkowicz, Merit E.; Genge, Angela; Oskarsson, Björn; Hains, Avis B.; Chen, Chen; Galanter, Joshua; Burgess, Braydon L.; Cho, William; Kerchner, Geoffrey A.; Yeh, Felix L.; Ghosh, Arundhati Sengupta; Cheeti, Sravanthi; Brooks, Logan; Honigberg, Lee; Couch...
Journal:
Annals of clinical and translational neurology
Issue:
Volume 9:Issue 1(2022)
Page Start:
50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury. Issue 1 (12th August 2018)

Authors:
Rothenberg, Michael E.; Wang, Yehong; Lekkerkerker, Annemarie; Danilenko, Dimitry M.; Maciuca, Romeo; Erickson, Rich; Herman, Ann; Stefanich, Eric; Lu, Timothy T.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 1(2019)
Page Start:
177
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗